Published Date: 15 Dec 2023
More patients experienced reductions when pelabresib or navitoclax were combined.
Read Full NewsA 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.
The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.
Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.
Dr Anne Peters discusses the varying subtypes of diabetes.
Cardiologists Bob Harrington and Lisa Rosenbaum discuss the loss of trust in medicine, how it may reflect patients’ desire for agency, and strategies to earn it back.
A 20-year-old man on daily finasteride suffers an ischemic stroke with multifocal carotid stenoses and multiple prothrombotic genetic variants — could the drug be implicated?
Medical specialties in which most doctors think they have either a promising or grim near-term (next 3 years) future are revealed.
1.
"We Caught It Early": Advantage or Disadvantage?
2.
Scientists develop scans that light up aggressive cancer tumors for better treatment
3.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
4.
Future of Lab-Developed Tests Still Taking Shape
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
2.
Evolution of Cancer Care Through Developmental Therapeutics
3.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
4.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
5.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
Navigating the Complexities of Ph Negative ALL - Part VI
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
5.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation